OasisLMS

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a specific subset of lung cancer: EGFR exon 20 insertion NSCLC. Joining the podcast is a distinguished panel of clinicians and lung cancer advocates.

Podcast Hosts:

• Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

• Rosario Garcia Campelo, MD, Head of Medical Oncology Department, Thoracic Tumors Unit, University Hospital A Coruña, Biomedical Research Institute (INIBIC, A Coruña), Coruña, Spain
• Byoung-Chul Cho, MD, PhD, Professor, Division of Medical Oncology, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, South Korea
• Marcia Horn, JD, Executive Director, Exon 20 Group; President and CEO, International Cancer Advocacy Network (ICAN), Phoenix, AZ, USA